Cargando…
Knockdown Of lncRNA NCK-AS1 Regulates Cisplatin Resistance Through Modulating miR-137 In Osteosarcoma Cells
PURPOSE: Long non-coding RNAs (lncRNAs) have been proved to act crucial parts in the progress of human tumor. However, the role of lncRNAs in drug resistance of tumor cells remains to be further elucidated. The present study aimed to explore whether lncRNA NCK-AS1 could affect the cisplatin (DDP) re...
Autores principales: | Cheng, Yi, Shen, Xiaofei, Zheng, Minqian, Zou, Guoyou, Shen, Yixin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924660/ https://www.ncbi.nlm.nih.gov/pubmed/31908475 http://dx.doi.org/10.2147/OTT.S228199 |
Ejemplares similares
-
Knockdown of the oncogene lncRNA NEAT1 restores the availability of miR-34c and improves the sensitivity to cisplatin in osteosarcoma
por: Hu, Yuliang, et al.
Publicado: (2018) -
LncRNA HOTTIP Participates in Cisplatin Resistance of Tumor Cells by Regulating miR-137 Expression in Pancreatic Cancer
por: Yin, Feng, et al.
Publicado: (2020) -
LncRNA NCK1-AS1 promotes proliferation and induces cell cycle progression by crosstalk NCK1-AS1/miR-6857/CDK1 pathway
por: Li, Haiyu, et al.
Publicado: (2018) -
Knockdown of NCK1-AS1 inhibits the development of atherosclerosis by targeting miR-1197/COX10 axis
por: Zhang, Bin, et al.
Publicado: (2022) -
LncRNA HAS2-AS1 Promotes Glioblastoma Proliferation by Sponging miR-137
por: Lu, Yalin, et al.
Publicado: (2021)